FTSE 100: Index falls as earnings results weigh; pound below $1.33, Bodycote soars
NEW YORK—Mills Stacy, Vice President and Controller at Marsh & McLennan Companies, Inc. (NYSE:MMC), recently sold 1,317 shares of the company’s common stock. The transaction, which took place on March 10, 2025, was executed at a price of $234.97 per share, amounting to a total sale value of $309,455. Following the sale, Stacy retains ownership of approximately 2,923 shares in the company.
The transaction was conducted under a pre-established Rule 10b5-1 trading plan, which allows company insiders to set up a predetermined schedule for selling stocks. This sale represents a routine adjustment in Stacy’s holdings, as part of personal financial planning. With a market capitalization of $114.46 billion and a P/E ratio of 28.29, InvestingPro analysis suggests the stock is currently trading above its Fair Value.
Marsh & McLennan Companies, a leading professional services firm specializing in risk, strategy, and human capital, continues to be a significant player in the insurance and consulting industries.
In other recent news, Marsh & McLennan reported robust fourth-quarter 2024 earnings, with an adjusted earnings per share (EPS) of $1.87, surpassing the forecasted $1.77. The company’s revenue reached $6.07 billion, exceeding expectations of $5.93 billion, marking a 9% year-over-year increase. In strategic moves, Mercer (NASDAQ:MERC), part of Marsh McLennan, announced its agreement to acquire SECOR Asset Management, a deal expected to close in the second quarter of 2025. This acquisition aims to enhance Mercer’s investment solutions for institutional investors, with SECOR managing $21.5 billion in assets as of September 30, 2024.
Analyst activity around Marsh & McLennan has been varied. Raymond (NSE:RYMD) James increased the price target for the company’s shares to $250, maintaining a Strong Buy rating, citing potential for higher organic growth and improved margins. Conversely, Keefe, Bruyette & Woods reduced their price target from $214 to $210, maintaining an Underperform rating due to anticipated lower margins in the Risk and Insurance Services segment. Goldman Sachs reiterated a Sell rating with a price target of $204, citing challenges in achieving growth and margin estimates.
The company also completed significant acquisitions, such as McGriff, which is expected to contribute to future earnings. However, Goldman Sachs expressed concerns over Marsh & McLennan’s free cash flow trajectory and capital deployment, revising its capital deployment guidance to $4.5 billion. These developments reflect Marsh & McLennan’s strategic efforts and the mixed analyst sentiment surrounding its financial outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.